Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth

Related Experiment Video

Updated: Aug 24, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Young Nyun Park1, Kwang Jo Chae, Bong-Kyeong Oh

  • 1Department of Pathology and Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.

Hepato-Gastroenterology
|April 17, 2004
PubMed
Abstract

Insights

Smad7 expression in tumor cells is a resistance mechanism to transforming growth factor-beta1 in advanced hepatocellular carcinoma. Smad4 in stellate cells may also contribute to host resistance during hepatocarcinogenesis.

Area of Science:

  • Hepatocellular Carcinoma Research
  • Molecular Biology
  • Cancer Signaling Pathways

Background:

  • Transforming growth factor-beta (TGF-β) signaling is crucial in regulating cell proliferation and is often dysregulated in cancer.
  • Understanding resistance mechanisms to TGF-β's antiproliferative effects is vital for treating human multistep hepatocarcinogenesis.
  • Smad7 acts as an inhibitory Smad within the TGF-β pathway.

Purpose of the Study:

  • Investigate Smad7 and Smad4 expression in human hepatocarcinogenesis.
  • Determine the role of Smad7 and Smad4 in resistance to TGF-β signaling.
  • Analyze the correlation between Smad7, Smad4, TGF-β1, and TGF-β receptor II in hepatocellular carcinoma (HCC) progression.

Main Methods:

  • Immunohistochemistry was used to evaluate Smad7 and Smad4 expression in dysplastic nodules (DNs) and HCC tissues.
  • RT-PCR analyzed the mRNA levels of TGF-β1 and TGF-β receptor II in HCC and non-HCC tissues.
  • Statistical analysis compared protein and mRNA expression levels across different stages of liver disease.

Main Results:

  • Smad7 immunoreactivity was detected in 61% of advanced HCCs but not in DNs or early HCCs.
  • Advanced HCCs showed significantly higher Smad7 expression with increased TGF-β1 or unchanged TGF-β receptor II.
  • Smad4 expression was observed in 68% of advanced HCCs, correlating with smaller size and better differentiation.

Conclusions:

  • Tumor cell Smad7 expression represents a resistance mechanism to elevated TGF-β1 in advanced HCC.
  • Smad7 is implicated in resistance to TGF-β1 in late-stage hepatocarcinogenesis, particularly when TGF-β receptor II is not downregulated.
  • Stellate cell Smad4 expression may play a role in the host's resistance to hepatocarcinogenesis.

More Related Videos

Spheroid Assay to Measure TGF-β-induced Invasion09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines08:50

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...